The role of scavenger receptor MARCO in hepatic fibrosis and non-alcoholic steatohepatitis 3513

Abstract Description Obesity is a risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD), which can progress to steatohepatitis (MASH) and fibrosis. We explored how macrophage remodeling influences this progression, focusing on the role of the macrophage receptor with collagenous structure (MARCO) therein. Wild-type and Marco-/- mice were fed a normal or choline-deficient high-fat diet (CDHFD) for 15 weeks. Kupffer cells (KC) were analyzed by flow cytometry, fibrosis, and steatosis were assessed histologically. RNA sequencing along with non-targeted metabolomics were performed on liver tissue. High fibrosis after CDHFD was linked to the replacement of resident KC by monocyte-derived macrophages. RNA sequencing showed increased immune responses and decreased metabolic activity, with mitochondrial function negatively and lipid-laden KC positively correlating with fibrosis. MARCO was upregulated on KC during CDHFD feeding. Obese Marco-/- mice exhibited altered KC inflammation, bile acid metabolism, reduced KC lipid content, and increased steatosis, but lower liver injury and fibrosis than controls. Notably, MARCO expression in KC of obese patients positively correlated with insulin resistance and liver injury. These results suggest that macrophage remodeling and reduced mitochondrial fatty acid metabolism perpetuate fibrosis. They further indicate that MARCO-expressing KC influence the balance between steatosis and fibrosis by modulating KC lipid profiles and inflammation. Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.1308
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of scavenger receptor MARCO in hepatic fibrosis and non-alcoholic steatohepatitis 3513

Omar Sharif, Ana Korosec, Aloña Agirre‐Lizaso, Anna Gemza et al.
The Journal of Immunology
Liver Disease Diagnosis and Treatment
article

The role of scavenger receptor MARCO in hepatic fibrosis and non-alcoholic steatohepatitis 3513

Omar Sharif, Ana Korosec, Aloña Agirre‐Lizaso, Anna Gemza, Anja Dobrijević, Hon Shing Lam, Lenka Matejovicova
article en

Abstract

Abstract Description Obesity is a risk factor for metabolic dysfunction-associated fatty liver disease (MAFLD), which can progress to steatohepatitis (MASH) and fibrosis. We explored how macrophage remodeling influences this progression, focusing on the role of the macrophage receptor with collagenous structure (MARCO) therein. Wild-type and Marco-/- mice were fed a normal or choline-deficient high-fat diet (CDHFD) for 15 weeks. Kupffer cells (KC) were analyzed by flow cytometry, fibrosis, and steatosis were assessed histologically. RNA sequencing along with non-targeted metabolomics were performed on liver tissue. High fibrosis after CDHFD was linked to the replacement of resident KC by monocyte-derived macrophages. RNA sequencing showed increased immune responses and decreased metabolic activity, with mitochondrial function negatively and lipid-laden KC positively correlating with fibrosis. MARCO was upregulated on KC during CDHFD feeding. Obese Marco-/- mice exhibited altered KC inflammation, bile acid metabolism, reduced KC lipid content, and increased steatosis, but lower liver injury and fibrosis than controls. Notably, MARCO expression in KC of obese patients positively correlated with insulin resistance and liver injury. These results suggest that macrophage remodeling and reduced mitochondrial fatty acid metabolism perpetuate fibrosis. They further indicate that MARCO-expressing KC influence the balance between steatosis and fibrosis by modulating KC lipid profiles and inflammation. Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

The Journal of ImmunologyVol. 214(Supplement_1)
University of Vienna (AT), Medical University of Vienna (AT)
National Research Foundation, Ministry of Science and ICT, South Korea
Openalex Percentile: Top 53%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.